Data Further Position ELAHERE to Become the New Standard of Care for Patients with FRĪ±-Positive Platinum-Resistant Ovarian Cancer
Findings to be Highlighted in Oral Presentation at ESGO Annual.
Immunogen (IMGN) Announces ELAHERE Shows Overall and PFS Benefit Regardless of Prior PARPi Exposure or Prior Lines of Therapy in FRα-Positive Platinum-Resistant Ovarian Cancer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.